What is the primary treatment approach for ulcers associated with Behcet syndrome?

The primary treatment approach for ulcers associated with Behcet syndrome involves the use of topical glucocorticoids. Behcet syndrome is characterized by recurrent oral and genital ulcers, as well as ocular symptoms. Topical glucocorticoids are effective in reducing inflammation and promoting healing of the painful oral and genital ulcers, providing symptomatic relief for patients.

While systemic NSAIDs may alleviate pain and inflammation, they do not directly target the underlying inflammation associated with the ulcers of Behcet syndrome. Similarly, while colchicine is useful for conditions like gout or familial Mediterranean fever, it is not a primary treatment for Behcet syndrome. Immunosuppressants may be considered for more severe systemic manifestations of the disease, but for localized ulcer treatment, topical glucocorticoids are the preferred option due to their targeted action and lower side effect profile when used topically.